SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

09 Aug 2022 Evaluate
The turnover for the June 2022 quarter moved up 64.80% to Rs. 1036.10 millions as compared to Rs. 628.70 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -248.30 millions as compared to Net Loss of Rs. -135.20 millions of corresponding quarter ended June 2021The company reported a degrowth in operating Profit to 75.60 millions from 223.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1036.10 628.70 64.80 1036.10 628.70 64.80 3027.90 2003.20 51.15
Other Income 50.00 182.80 -72.65 50.00 182.80 -72.65 657.10 661.50 -0.67
PBIDT 75.60 223.20 -66.13 75.60 223.20 -66.13 999.00 135.00 640.00
Interest 126.00 77.90 61.75 126.00 77.90 61.75 372.30 341.70 8.96
PBDT -50.40 145.30 -134.69 -50.40 145.30 -134.69 567.60 -206.70 -374.60
Depreciation 346.50 348.80 -0.66 346.50 348.80 -0.66 1400.70 1413.50 -0.91
PBT -396.90 -203.50 95.04 -396.90 -203.50 95.04 -833.10 -1620.20 -48.58
TAX -148.60 -68.30 117.57 -148.60 -68.30 117.57 -528.40 641.20 -182.41
Deferred Tax -148.60 -68.30 117.57 -148.60 -68.30 117.57 -221.60 461.50 -148.02
PAT -248.30 -135.20 83.65 -248.30 -135.20 83.65 -304.70 -2261.40 -86.53
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 7.30 35.50 -79.45 7.30 35.50 -79.45 32.99 6.74 389.57

Dishman Carbogen Amc Share Price

168.60 -2.00 (-1.17%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×